Received Oct 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | IM |
get sick after it every time/getting sick; dizziness; nausea/general queasiness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (get sick after it every time/getting sick), DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness) in a 75-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. In October 2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On an unknown date, the patient experienced ILLNESS (get sick after it every time/getting sick), DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness). At the time of the report, ILLNESS (get sick after it every time/getting sick), DIZZINESS (dizziness) and NAUSEA (nausea/general queasiness) outcome was unknown. For mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use), the reporter did not provide any causality assessments. Concomitant medication was not provided. The patient had not taken any other vaccines in the past 4 weeks. It was reported that the patient's most recent vaccine was administered two days prior. And reported that the patient was over 65 years old, received a COVID-19 vaccine approximately every three months, typically before traveling. It was explained that she requested the vaccine by her selves and were not following any medical recommendation. Reporter added that she received multiple doses each year and experienced illness after each one. When asked whether the patient consistently received the Moderna vaccine, reporter responded that did not know exactly which one she was taking. It was noted that the patient experienced symptoms such as nausea, dizziness, and general queasiness symptoms described as matching those listed as common side effects and also remarked that she was generally less symptomatic. It was unknown if the patient experienced any additional symptoms or events. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-790352, US-MODERNATX, INC.-MOD-2025-790353, US-MODERNATX, INC.-MOD-2025-790363, US-MODERNATX, INC.-MOD-2025-790362 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-790353:mother case spikevax nos case US-MODERNATX, INC.-MOD-2025-790352:husband case US-MODERNATX, INC.-MOD-2025-790362:SPIKEVAX NOS father case US-MODERNATX, INC.-MOD-2025-790363:Daughter case